Market Summary
USD28.80+0.42
Delayed1.48%
CC Stock Price
CC RSI Chart
CC Valuation
CC Price/Sales (Trailing)
CC Profitability
CC Fundamentals
CC Revenue
CC Earnings
Price Action
52 Week Range
23.4044.30
(Low)(High)
Last 7 days
-2.0%
Last 30 days
-14.1%
Last 90 days
-6.4%
Trailing 12 Months
-8.1%
CC Financial Health
CC Investor Care
Peers (Alternatives to Chemours)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
DD | 34.3B | 13.0B | -5.91% | -9.14% | 5.84 | 2.63 | 3.59% | -9.26% |
ALB | 25.5B | 7.3B | -11.63% | 1.86% | 9.49 | 3.49 | 119.96% | 2074.96% |
FMC | 14.8B | 5.8B | -8.58% | -11.28% | 20.13 | 2.56 | 15.01% | -0.42% |
CE | 11.0B | - | -11.07% | -28.10% | 5.82 | 1.15 | 22.25% | 0.21% |
| MID-CAP | ||||||||
EMN | 9.5B | 10.6B | -4.57% | -27.51% | 12.04 | 0.9 | 0.99% | -7.47% |
OLN | 6.9B | 9.4B | -13.84% | -1.19% | 5.17 | 0.73 | 5.23% | 2.33% |
HUN | 4.9B | 8.0B | -7.01% | -33.03% | 10.74 | 0.62 | 4.60% | -55.98% |
CC | 4.3B | 6.8B | -14.13% | -8.14% | 7.4 | 0.63 | 7.08% | -4.93% |
BCPC | 3.9B | 942.4M | -8.55% | -10.54% | 37.42 | 4.18 | 17.94% | 9.64% |
LTHM | 3.7B | 813.2M | -11.23% | -19.45% | 13.6 | 4.57 | 93.43% | 45483.33% |
GCP | 2.4B | 999.6M | 1.27% | 44.25% | 215.39 | 2.37 | 3.34% | -90.08% |
| SMALL-CAP | ||||||||
KRO | 1.0B | 1.9B | -21.72% | -45.67% | 9.68 | 0.52 | -0.47% | -7.44% |
GURE | 28.1M | 68.4M | -18.79% | -37.09% | 2.41 | 0.41 | 48.74% | 2401.42% |
Financials for Chemours
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | -3.4% | 6,794 | 7,031 | 6,934 | 6,674 | 6,345 |
| Gross Profit | -10.6% | 1,616 | 1,808 | 1,803 | 1,570 | 1,381 |
| Operating Expenses | 2.6% | 844 | 823 | 806 | 730 | 705 |
| S&GA Expenses | 2.3% | 710 | 694 | 678 | 596 | 592 |
| R&D Expenses | 1.7% | 118 | 116 | 111 | 113 | 107 |
| EBITDA | -23.9% | 1,195 | 1,570 | 1,512 | 1,339 | - |
| EBITDA Margin | -21.2% | 0.18* | 0.22* | 0.22* | 0.20* | - |
| Earnings Before Taxes | -33.4% | 741 | 1,112 | 1,044 | 857 | 676 |
| EBT Margin | -31.0% | 0.11* | 0.16* | 0.15* | 0.13* | - |
| Interest Expenses | -1.2% | 163 | 165 | 169 | 176 | 185 |
| Net Income | -36.3% | 578 | 908 | 882 | 747 | 608 |
| Net Income Margin | -34.1% | 0.09* | 0.13* | 0.13* | 0.11* | - |
| Free Cahsflow | -7.8% | 447 | 485 | 500 | 460 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | -1.4% | 7,640 | 7,745 | 7,730 | 7,524 | 7,550 |
| Current Assets | -9.3% | 3,214 | 3,543 | 3,606 | 3,393 | 3,345 |
| Cash Equivalents | -5.6% | 1,102 | 1,167 | 1,248 | 1,145 | 1,451 |
| Inventory | 6.3% | 1,404 | 1,321 | 1,219 | 1,166 | 1,099 |
| Net PPE | 3.3% | 3,171 | 3,071 | 3,111 | 3,131 | 3,154 |
| Goodwill | 0% | 102 | 102 | 102 | 102 | 102 |
| Liabilities | 1.1% | 6,533 | 6,460 | 6,515 | 6,357 | 6,468 |
| Current Liabilities | -3.1% | 1,891 | 1,951 | 1,886 | 1,775 | 1,858 |
| Long Term Debt | -4.0% | 3,510 | 3,656 | 3,692 | 3,724 | - |
| LT Debt, Non Current | 2.3% | 3,590 | 3,510 | 3,656 | 3,692 | 3,724 |
| Shareholder's Equity | -13.8% | 1,107 | 1,284 | 1,215 | 1,167 | 1,081 |
| Retained Earnings | -5.8% | 2,170 | 2,304 | 2,102 | 1,940 | 1,746 |
| Additional Paid-In Capital | 0.1% | 1,016 | 1,015 | 1,005 | 956 | 944 |
| Accumulated Depreciation | 1.7% | 6,216 | 6,115 | 6,153 | 6,123 | 6,078 |
| Shares Outstanding | -3.0% | 149 | 153 | 156 | 157 | 161 |
| Minority Interest | 0% | 1.00 | 1.00 | 1.00 | 1.00 | - |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | -6.7% | 754 | 808 | 818 | 783 | 820 |
| Share Based Compensation | -20.6% | 27.00 | 34.00 | 31.00 | 32.00 | 34.00 |
| Cashflow From Investing | -239.9% | -284 | 203 | 209 | 187 | 220 |
| Cashflow From Financing | 1.6% | -685 | -696 | -762 | -707 | -560 |
| Dividend Payments | -2.5% | 154 | 158 | 160 | 163 | 164 |
| Buy Backs | 11.5% | 495 | 444 | 432 | 317 | 173 |
Risks for CC
What is the probability of a big loss on CC?
86.2%
Probability that Chemours stock will be more than 20% underwater in next one year
65.4%
Probability that Chemours stock will be more than 30% underwater in next one year.
57.3%
Probability that Chemours stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does CC drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Chemours was unfortunately bought at previous high price.
Drawdowns
Returns for CC
Cumulative Returns on CC
25.7%
7-Year Cumulative Returns
-5.8%
5-Year Cumulative Returns
49.7%
3-Year Cumulative Returns
What are the long-term rolling returns for CC?
FIve years rolling returns for Chemours.
Annualized Returns
Which funds bought or sold CC recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | new | - | 201,773 | 201,773 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -0.02 | 205,471 | 1,052,470 | -% |
2023-03-08 | SHEETS SMITH WEALTH MANAGEMENT | sold off | -100 | -274,000 | - | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 46.86 | 514,000 | 1,136,000 | 0.01% |
2023-03-03 | ROBOTTI ROBERT | reduced | -0.8 | 687,086 | 3,644,090 | 0.73% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 377,239 | 377,239 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -21.28 | -31,707 | 1,398,290 | -% |
2023-02-24 | NATIXIS | new | - | 2,118,900 | 2,118,900 | 0.01% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -6.04 | 110,000 | 763,000 | 0.01% |
2023-02-22 | CVA Family Office, LLC | reduced | -86.67 | -7,469 | 1,531 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Chemours News
Schedule 13G FIlings of Chemours
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | sessa capital (master), l.p. | 0.36% | 547,057 | SC 13G/A | |
| Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 12.20% | 18,416,153 | SC 13G/A | |
| Jan 26, 2023 | blackrock inc. | 12.3% | 18,516,903 | SC 13G/A | |
| Jan 20, 2023 | blackrock inc. | 12.3% | 18,516,903 | SC 13G/A | |
| Apr 08, 2022 | blackrock inc. | 11.3% | 18,075,740 | SC 13G/A | |
| Feb 14, 2022 | sessa capital (master), l.p. | 3.6% | 5,748,120 | SC 13G/A | |
| Feb 09, 2022 | vanguard group inc | 9.98% | 16,258,762 | SC 13G/A | |
| Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
| Feb 03, 2022 | blackrock inc. | 8.6% | 14,015,490 | SC 13G/A |
CC Fair Value
Chemours fair value in different scenarios
The table shows the Fair Value estimates for Chemours for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | 21.94 -23.82% | 31.44 9.17% | 52.76 83.19% | 71.62 148.68% | 84.17 192.26% |
| Current Inflation | 20.93 -27.33% | 29.71 3.16% | 47.69 65.59% | 63.85 121.70% | 74.51 158.72% |
| Very High Inflation | 19.61 -31.91% | 27.48 -4.58% | 41.56 44.31% | 54.63 89.69% | 63.14 119.24% |
Historical Chemours Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of Chemours
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 23, 2023 | 8-K | Current Report | |
| Mar 16, 2023 | 8-K | Current Report | |
| Mar 15, 2023 | 8-K | Current Report | |
| Mar 10, 2023 | 4/A | Insider Trading | |
| Mar 10, 2023 | DEFA14A | DEFA14A | |
| Mar 10, 2023 | DEF 14A | DEF 14A | |
| Mar 10, 2023 | ARS | ARS | |
| Mar 10, 2023 | 4/A | Insider Trading | |
| Mar 10, 2023 | 4/A | Insider Trading | |
| Mar 10, 2023 | 4/A | Insider Trading |
Latest Insider Trading transactions for CC
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-06 | Bellezza Alisha | acquired | 658,266 | 23.7504 | 27,716 | president, thermal spec solns |
2023-03-06 | Bellezza Alisha | sold | -983,086 | 35.47 | -27,716 | president, thermal spec solns |
2023-03-02 | Dignam Denise | sold (taxes) | -20,552 | 36.12 | -569 | president, adv perf materials |
2023-03-02 | Sparks Edwin C | sold (taxes) | -653,014 | 36.12 | -18,079 | president, titan tech chem sol |
2023-03-02 | Scarborough Alvenia | sold (taxes) | -20,227 | 36.12 | -560 | svp corp communications & cbo |
2023-03-02 | Wellman Kristine M | sold (taxes) | -18,674 | 36.12 | -517 | svp, gc & corp. secretary |
2023-03-02 | Wisel Camela | sold (taxes) | -17,590 | 36.12 | -487 | vp, cao & controller |
2023-03-02 | Bellezza Alisha | sold (taxes) | -34,061 | 36.12 | -943 | president, thermal spec solns |
2023-03-01 | Newman Mark | sold (taxes) | -182,840 | 34.84 | -5,248 | president and ceo |
2023-03-01 | Scarborough Alvenia | acquired | - | - | 2,332 | svp corp communications & cbo |
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
CC Income Statement
2022-09-30Interim Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
| Income Statement [Abstract] | ||||
| Net sales | $ 1,777 | $ 1,680 | $ 5,456 | $ 4,770 |
| Cost of goods sold | 1,345 | 1,253 | 4,042 | 3,782 |
| Gross profit | 432 | 427 | 1,414 | 988 |
| Selling, general, and administrative expense | 140 | 124 | 535 | 433 |
| Research and development expense | 32 | 27 | 88 | 78 |
| Restructuring, asset-related, and other charges | (1) | 3 | 10 | 4 |
| Total other operating expenses | 171 | 154 | 633 | 515 |
| Equity in earnings of affiliates | 16 | 12 | 44 | 32 |
| Interest expense, net | (41) | (45) | (123) | (142) |
| Gain (loss) on extinguishment of debt | 7 | (20) | 7 | (20) |
| Other income, net | 56 | 11 | 101 | 31 |
| Income before income taxes | 299 | 231 | 810 | 374 |
| Provision for (benefit from) income taxes | 59 | 17 | 135 | (1) |
| Net income | 240 | 214 | 675 | 375 |
| Net income attributable to Chemours | $ 240 | $ 214 | $ 675 | $ 375 |
| Per share data | ||||
| Basic earnings per share of common stock | $ 1.54 | $ 1.30 | $ 4.30 | $ 2.26 |
| Diluted earnings per share of common stock | $ 1.52 | $ 1.27 | $ 4.21 | $ 2.21 |
CC Balance Sheet
2022-09-30Interim Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Sep. 30, 2022 | Dec. 31, 2021 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 1,167 | $ 1,451 |
| Accounts and notes receivable, net | 980 | 720 |
| Inventories | 1,321 | 1,099 |
| Prepaid expenses and other | 75 | 75 |
| Total current assets | 3,543 | 3,345 |
| Property, plant, and equipment | 9,186 | 9,232 |
| Less: Accumulated depreciation | (6,115) | (6,078) |
| Property, plant, and equipment, net | 3,071 | 3,154 |
| Operating lease right-of-use assets | 232 | 227 |
| Goodwill | 102 | 102 |
| Other intangible assets, net | 15 | 6 |
| Investments in affiliates | 186 | 169 |
| Restricted cash and restricted cash equivalents | 201 | 100 |
| Other assets | 395 | 447 |
| Total assets | 7,745 | 7,550 |
| Current liabilities: | ||
| Accounts payable | 1,270 | 1,162 |
| Compensation and other employee-related cost | 130 | 173 |
| Short-term and current maturities of long-term debt | 24 | 25 |
| Current environmental remediation | 210 | 173 |
| Other accrued liabilities | 317 | 325 |
| Total current liabilities | 1,951 | 1,858 |
| Long-term debt, net | 3,510 | 3,724 |
| Operating lease liabilities | 192 | 179 |
| Long-term environmental remediation | 482 | 389 |
| Deferred income taxes | 53 | 49 |
| Other liabilities | 272 | 269 |
| Total liabilities | 6,460 | 6,468 |
| Commitments and contingent liabilities (Note 16) | ||
| Equity | ||
| Common stock (par value $0.01 per share; 810,000,000 shares authorized; 195,178,578 shares issued and 153,078,931 shares outstanding at September 30, 2022; 191,860,159 shares issued and 161,046,732 shares outstanding at December 31, 2021) | 2 | 2 |
| Treasury stock, at cost (42,099,647 shares at September 30, 2022; 30,813,427 shares at December 31, 2021) | (1,604) | (1,247) |
| Additional paid-in capital | 1,015 | 944 |
| Retained earnings | 2,304 | 1,746 |
| Accumulated other comprehensive loss | (433) | (364) |
| Total Chemours stockholders’ equity | 1,284 | 1,081 |
| Non-controlling interests | 1 | 1 |
| Total equity | 1,285 | 1,082 |
| Total liabilities and equity | $ 7,745 | $ 7,550 |